13-110503163-C-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001846.4(COL4A2):ā€‹c.3920C>Gā€‹(p.Pro1307Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000237 in 1,613,954 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0013 ( 0 hom., cov: 33)
Exomes š‘“: 0.00013 ( 1 hom. )

Consequence

COL4A2
NM_001846.4 missense

Scores

10
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.79
Variant links:
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021410674).
BP6
Variant 13-110503163-C-G is Benign according to our data. Variant chr13-110503163-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 392751.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00125 (191/152306) while in subpopulation AFR AF= 0.00428 (178/41564). AF 95% confidence interval is 0.00377. There are 0 homozygotes in gnomad4. There are 109 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 191 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL4A2NM_001846.4 linkuse as main transcriptc.3920C>G p.Pro1307Arg missense_variant 42/48 ENST00000360467.7 NP_001837.2 P08572A0A024RDW8
COL4A2-AS1NR_046583.1 linkuse as main transcriptn.187-235G>C intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL4A2ENST00000360467.7 linkuse as main transcriptc.3920C>G p.Pro1307Arg missense_variant 42/485 NM_001846.4 ENSP00000353654.5 P08572
COL4A2ENST00000650225.1 linkuse as main transcriptn.1575C>G non_coding_transcript_exon_variant 13/19
COL4A2-AS1ENST00000417970.2 linkuse as main transcriptn.187-235G>C intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00126
AC:
191
AN:
152188
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000719
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000273
AC:
68
AN:
249138
Hom.:
0
AF XY:
0.000251
AC XY:
34
AN XY:
135256
show subpopulations
Gnomad AFR exome
AF:
0.00408
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000884
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000131
AC:
192
AN:
1461648
Hom.:
1
Cov.:
35
AF XY:
0.000110
AC XY:
80
AN XY:
727146
show subpopulations
Gnomad4 AFR exome
AF:
0.00496
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000348
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
8.99e-7
Gnomad4 OTH exome
AF:
0.000232
GnomAD4 genome
AF:
0.00125
AC:
191
AN:
152306
Hom.:
0
Cov.:
33
AF XY:
0.00146
AC XY:
109
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.00428
Gnomad4 AMR
AF:
0.000718
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.000215
Hom.:
0
Bravo
AF:
0.00150
ESP6500AA
AF:
0.00595
AC:
22
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000331
AC:
40
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 21, 2020In silico analysis supports that this missense variant has a deleterious effect on protein structure/function -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 05, 2023- -
COL4A2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 27, 2021This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 22, 2022This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Porencephaly 2 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Uncertain
-0.040
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.58
D
Eigen
Benign
0.034
Eigen_PC
Benign
0.036
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.71
T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.021
T
MetaSVM
Uncertain
0.26
D
MutationAssessor
Benign
1.2
L
PrimateAI
Uncertain
0.58
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.57
Sift
Uncertain
0.0090
D
Sift4G
Benign
0.31
T
Polyphen
0.75
P
Vest4
0.56
MVP
0.92
MPC
1.0
ClinPred
0.098
T
GERP RS
4.6
Varity_R
0.27
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201627758; hg19: chr13-111155510; API